NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 64 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $154,000 | -59.2% | 244,395 | -40.7% | 0.00% | -100.0% |
Q3 2016 | $377,000 | +45.0% | 412,210 | -15.9% | 0.00% | – |
Q2 2016 | $260,000 | +36.1% | 489,990 | +142.3% | 0.00% | – |
Q1 2016 | $191,000 | +38.4% | 202,241 | +95.5% | 0.00% | – |
Q4 2015 | $138,000 | +228.6% | 103,444 | +293.9% | 0.00% | – |
Q2 2015 | $42,000 | -28.8% | 26,263 | -16.0% | 0.00% | – |
Q4 2014 | $59,000 | +268.8% | 31,282 | +183.2% | 0.00% | – |
Q2 2014 | $16,000 | -77.5% | 11,045 | -58.5% | 0.00% | – |
Q3 2013 | $71,000 | – | 26,619 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|